Type-II Variation: Waive in-vivo study by providing in-vitro data? [Study As­sess­ment]

posted by qualityassurance – 2024-07-02 13:29 (225 d 12:04 ago) – Posting: # 24054
Views: 1,987

Dear Helmut,

Thank you for the response.

Is it possible to waive in-vivo study if we achieve similar in-vitro dissolution profile in multimedia between test products (BE batch vs new formulation) having different particle size?

Regards,
QA

Complete thread:

UA Flag
Activity
 Admin contact
23,380 posts in 4,914 threads, 1,661 registered users;
29 visitors (0 registered, 29 guests [including 5 identified bots]).
Forum time: 00:34 CET (Europe/Vienna)

Skill is a function of chance.
It’s an intuitive best-use of chance situations.    Philip K. Dick

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5